Ligustrazine Derivatives. Part 6: Design, Synthesis and Evaluation of Novel Ligustrazinyl Acylguanidine Derivatives as Potential Cardiovascular Agents

Author(s): Zhenyu Li, Fang Yu, Lei Cui, Peng Zhan, Shouxun Wang, Yuemao Shen, Xinyong Liu

Journal Name: Medicinal Chemistry

Volume 8 , Issue 5 , 2012

Become EABM
Become Reviewer
Call for Editor


A series of novel Ligustrazinyl acylguanidines was designed, synthesized and evaluated for their protective effect on injured vascular endothelial cell (ECV-304). The preliminary results demonstrated that some compounds possessed more potent activities than that of Ligustrazine in stimulating replication of the injured endothelial cell. Among the active compounds, compounds 8b, 8f and 8l displayed remarkable antioxidative activity with low EC50 values of 0.097, 0.059 and 0.094 mM, respectively. Structure-activity relationships were briefly discussed.

Keywords: Ligustrazine, Acylguanidines, Synthesis, Cardiovascular disease, endothelial cell, CVDs, vasodilator, pharmacokinetics, anticoagulant agents, exchanger

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 22 July, 2012
Page: [928 - 933]
Pages: 6
DOI: 10.2174/157340612802084243
Price: $65

Article Metrics

PDF: 17